STAR Trial with Ji-Hong Liu - a podcast by BMJ Group

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Dr. Ji-Hong Liu to discuss the STAR Trial. Dr. Liu is a Professor in the Department of Gynecologic Oncology at Sun Yat-sen University Cancer Center. He is also President-elect of the Gynecologic Oncology Committee of China Anti-Cancer Association.Highlights:
- In post-surgery treatment setting, adjuvant sequential chemoradiation was associated with improved disease-free survival compared with radiation alone or concurrent chemoradiation, and was well tolerated.- Sequential chemoradiation also decreased the risk of death compared with radiation alone.
- Neither disease-free survival nor cancer death risk was different between patients treated with concurrent chemoradiation or radiation alone.- The detailed QOL results in comparisons between three arms will be orally presented at the annual meeting of SGO 2021 in March.

- In conclusion, sequential chemoradiation (SCRT) after radical surgery resulted in a better disease-free survival and lower risk of cancer death for cervical cancer patients with adverse pathological factor, and could be an optimal adjuvant treatment in this setting.

Further episodes of IJGC Podcast

Further podcasts by BMJ Group

Website of BMJ Group